Research indicates that during menopause, varying FSH levels are linked with diverse health implications.
Low FSH levels are possibly associated with an enhanced risk of metabolic syndrome, insulin resistance, and diabetes, reflecting the hormone's role in energy and glucose metabolism.
Conversely, high FSH levels might lead to decreased bone mineral density, renal dysfunction, and increased cholesterol levels, underscoring FSH’s impact on bone and renal health and lipid metabolism.
Despite these risks, higher FSH levels have been associated with a decreased likelihood of metabolic disorders, including type 2 diabetes. These findings emphasize the multifaceted and significant influence of FSH on postmenopausal health, highlighting the need for continued exploration and understanding.
CLICK HERE to learn more about Postmenopausal FSH, health consequences, etc.